Shares of Modena fell 4.4%, Pfizer fell 2%, Novavax fell nearly 1% and BioNTech fell 2.6%. The US Senate Finance Committee supported the nomination of "anti-vaccine" Kennedy Jr., the US health secretary.
Pfizer rose premarket, up more than 2.5%.
Pfizer (PFE. N) 2024 Q2 revenue 13.30 billion dollars, the same period last year 12.73 billion dollars, the market is expected to 13.07 billion dollars.
Pfizer (PFE. N) expects full-year revenue of $59.50 billion to $62.50 billion.